CGEM   $18.05  0.61% Market Open

Cullinan Therapeutics Inc
Total Cash 662.49M
totalCashPerShare 11.427
EBITDA -182.99M
Total Debt 2.73M
quickRatio 28.22
currentRatio 28.872
Total Revenue
debtToEquity 0.417
Revenue/Share
ROA -0.19042999
ROE -0.24937999
grossProfits
freeCashflow -82.98M
operatingCashflow -126.81M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 380.92M
forwardPE -5.2951074
floatShares 38.28M
sharesOutstanding 57.98M
sharesShort 8.05M
sharesShortPriorMonth 8.36M
dateShortInterest
sharesPercentSharesOut 0.14%
heldPercentInsiders 0.05%
heldPercentInstitutions 1.15%
Short Ratio help_outline 13.17%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 11.339
Price To Book help_outline 1.53
earningsQuarterlyGrowth
netIncomeToCommon -142.16M
trailingEps -3.06%
forwardEps -3.27%
enterpriseToEbitda -2.08
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.81 3Q 2024
institutionsCount 196
lastUpdated Sept. 16, 2024, 8:10 p.m.